Daewoong pharmaceutical Co.,Ltd (069620.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 111,600.00

From 52W high−42.63%

Volume17588.00

Market capKRW 1.29T

P/E (TTM)6.6x

P/S (TTM)0.8x

Div yield0.54%

Key dataSep 18, 2026

Open

KRW 111,600.00

From 52W high

−42.63%

Volume

17588.00

Market cap

KRW 1.29T

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.5x

P/E (TTM)

6.6x

RSI (14)

36.3

MomentumView details →

1D Return

+2.20%

YTD Return

−36.62%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

6.6x

EV/EBITDA

8.5x

EV/Sales

1.3x

P/S (TTM)

0.8x

P/B (TTM)

1.2x

ProfitabilityView details →

Gross Margin

51.59%

Net Margin

11.95%

EBITDA Margin

15.63%

ROE (TTM)

18.37%

ROA (TTM)

7.70%

Asset Turnover

0.66x

GrowthView details →

Revenue YoY

+9.87%

EPS YoY

+160.27%

FCF YoY

−47.47%

Revenue CAGR 3Y

+7.06%

EPS CAGR 3Y

+64.61%

EBITDA YoY

+45.09%

MomentumView details →

1D Return

+2.20%

YTD Return

−36.62%

1Y Return

−22.83%

RSI (14)

36.3

vs 50D SMA

−10.11%

vs 200D SMA

−25.77%

Capital & dividendView details →

Debt/Equity

0.87x

Current Ratio

0.89x

Quick Ratio

0.52x

Div Yield

0.54%

Div Rate

KRW 600.00

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

KRW 1,718.89

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

4.42%

Financials snapshotView financials →

Revenue (TTM)

1.64T

Net Income (TTM)

195.47B

Op. CF (TTM)

162.15B

Next earningsNov 12, 2026 →

Latest newsMore news →

No recent news for 069620.KS.

Similar companies

JW Pharmaceutical Corporation001067.KS Celltrion Pharm, Inc.068760.KQ DongKook Pharmaceutical Co., Ltd.086450.KQ Chong Kun Dang Pharmaceutical Corp.185750.KS Humedix Co., Ltd.200670.KQ Shinpoong Pharmaceutical Co.,Ltd019175.KS Find similar companies →

Latest newsMore news →

No recent news for 069620.KS.